Artificial Intelligence vs Explainability
Embed automated risk screening and compliance validation natively inside self-service platforms so governance runs invisibly before any vendor is engaged.
CyberTRIZ analysis · Pharma contradiction D009 · one of 8,235 worked contradictions published by CyberTRIZ.AI
Regulations
Business Context
Artificial Intelligence increasingly supports pharmaceutical manufacturing, laboratory analytics, quality investigations, predictive maintenance, clinical development, and supply chain optimization. AI enables organizations to analyze complex datasets and identify patterns that traditional analytical methods may overlook. Many advanced machine learning models, however, operate through highly complex algorithms whose internal decision-making processes may not be easily interpretable by users or regulators.
The Contradiction
Artificial Intelligence improves analytical capability. Greater algorithm complexity may reduce explainability and regulatory confidence.
Why It Exists
Traditional computerized system validation assumes deterministic software behavior where outputs can be directly explained through predefined programming logic. Adaptive AI models challenge these assumptions by continuously learning from data.
Applying Pharmatriz
AI governance should emphasize transparency, documented model development, continuous performance monitoring, validation throughout the model lifecycle, and human oversight for regulated decisions. Explainability should become a design objective rather than an afterthought.